Malaysian Genomics Resource (0155) — Cash Flow Quality Index
Malaysian Genomics Resource (0155) has a Cash Flow Quality Index of 0.09x as of March 2026. Operating cash flow of RM98.00K is below net income of RM1.14 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Malaysian Genomics Resource cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Malaysian Genomics Resource Cash Flow Quality Index (2015–2022)
Historical Cash Flow Quality Index for Malaysian Genomics Resource across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 0155 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Malaysian Genomics Resource (2015–2022)
Year-by-year earnings quality comparison for Malaysian Genomics Resource. For live market cap and the full company financial profile, see market cap of Malaysian Genomics Resource.
| Year | Quality Index | Operating CF (MYR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | RM56.92K | RM7.21 Million | ▼ -98.8% |
| 2020 | 0.68x | RM11.67 Million | RM17.10 Million | ▼ -87.6% |
| 2017 | 5.50x | RM3.67 Million | RM668.26K | ▲ +160.8% |
| 2016 | 2.11x | RM3.68 Million | RM1.75 Million | ▲ +1833.3% |
| 2015 | 0.11x | RM395.83K | RM3.63 Million | — |